Back to top

Image: Bigstock

Can The Uptrend Continue for Reata Pharmaceuticals (RETA)?

Read MoreHide Full Article

Investors certainly have to be happy with Reata Pharmaceuticals, Inc. (RETA - Free Report) and its short term performance. After all, the stock has jumped by 10.9% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for RETA?

While we can never know for sure, it is pretty encouraging that estimates for RETA have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?

Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold.Be among the very first to see them >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Reata Pharmaceuticals, Inc. (RETA) - free report >>

Published in